Impact of the timing of hepatitis B virus identification and anti–hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy

Jessica P. Hwang, Maria E. Suarez-Almazor, Scott B. Cantor, Andrea Barbo, Heather Y. Lin, Sairah Ahmed, Mariana Chavez-MacGregor, Christian Donato-Santana, Cathy Eng, Alessandra Ferrajoli, Michael J. Fisch, Peter McLaughlin, George R. Simon, Gabriela Rondon, Elizabeth J. Shpall, Anna S. Lok

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of the timing of hepatitis B virus identification and anti–hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences